Delivery Order SPE2DB22D2211-SPE2DB25FSATS
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,426.28 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100S tablets on October 22, 2025, with completion expected by October 23, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under the company's broader relationship with DLA. The order is being fulfilled from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Atovaquone-Proguanil 250-100 tablets in a quantity of 100 units, with a ceiling value of $1,343.16. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside transaction. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $14,922.01 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets) on September 12, 2025, with a completion date of September 15, 2025. This is a firm fixed price order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets in a quantity of 100 units. This is a firm fixed-price delivery order valued at $10,073.70 with an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, the corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $7,718.44 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100-count units) with a ceiling value of $6,804.82. This is a firm fixed-price delivery order under a competitive, non-set-aside procurement. The order has an ultimate completion date of September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,100.20 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Atovaquone-Proguanil 250-100 (100 tablets). This is a firm fixed-price delivery order with no set-aside designation, demonstrating that the award was competitively procured. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,156.15 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,469.83 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Atovaquone-Proguanil 250-100mg in 100-count units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. The antimalarial medication delivery supports federal medical procurement requirements, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Atovaquone-Proguanil 250-100 mg tablets in quantities of 100 units, with a contract ceiling value of $27,644.83. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion by November 10, 2025, and will be performed at the contractor's Corporate Office...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSATSDelivery Order
The Defense Logistics Agency awarded a $4,599.31 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets in quantities of 100. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and was competitively awarded. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems, supplying a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies. The antimalarial medication being procured under this order supports the Defense Health Agency and other federal healthcare systems' medical supply chain requirements worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 7/14/25 |